Geron raises ~$150M in public offering of common stock and pre-funded warrants

GERON CORP

Offering of 42M shares at $3.00 and pre-funded warrants for 8M shares at $0.001 exercise price.
Each pre-funded warrant priced at $2.999; gross proceeds to Geron ~$150M before expenses.
Underwriters: Cowen and Company, LLC and Stifel, Nicolaus & Company; closing expected March 21, 2024.
Pre-funded warrants exercisable immediately, subject to 9.99% ownership cap (adjustable to 19.99%).
Offering made under existing shelf registration; representations and warranties standard for such deals.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

GERON CORP entered into Underwriting Agreement with Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated valued at approximately $150.0 million (effective 2024-03-19).

Action: entry
Agreement: underwriting
Counterparty: Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated
Value: approximately $150.0 million
Effective: 2024-03-19

Exact text from the filing

On March 19, 2024, Geron Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated, as representatives of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of 41,999,998 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and pre-funded warrants to purchase 8,002,668 shares of Common Stock (the “Pre-Funded Warrants”).

View on SEC.gov

290 material agreements filed in the last 30 days. Browse all material agreements →

GERON CORP filing history →

Source: SEC EDGAR

accession 0000950170-24-033921

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.